Genetically alteredmouse models: The good, the bad, and the ugly

被引:68
作者
Thyagarajan, T
Totey, S
Danton, MJS
Kulkarni, AB
机构
[1] Natl Inst Dent & Craniofacial Res, Funct Genom Unit, NIH, Bethesda, MD 20892 USA
[2] Natl Inst Dent & Craniofacial Res, Gene Targeting Facil, NIH, Bethesda, MD 20892 USA
关键词
craniofacial development; growth factors; hereditary disease; knockout mice; teeth; transgenic mice;
D O I
10.1177/154411130301400302
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Targeted gene disruption in mice is a powerful tool for generating murine models for human development and disease. While the human genome program has helped to generate numerous candidate genes, few genes have been characterized for their precise in vivo functions. Gene targeting has had an enormous impact on our ability to delineate the functional roles of these genes. Many gene knockout mouse models faithfully mimic the phenotypes of the human diseases. Because some models display an unexpected or no phenotype, controversy has arisen about the value of gene-targeting strategies. We argue in favor of gene-targeting strategies, provided they are used with caution, particularly in interpreting phenotypes in craniofacial and oral biology, where many genes have pleiotropic roles. The potential pitfalls are outweighed by the unique opportunities for developing and testing different therapeutic strategies before they are introduced into the clinic. In the future, we believe that genetically engineered animal models will be indispensable for gaining important insights into the molecular mechanisms underlying development, as well as disease pathogenesis, diagnosis, prevention, and treatment.
引用
收藏
页码:154 / 174
页数:21
相关论文
共 270 条
  • [1] ABBOTT BD, 1991, J CRAN GENET DEV BIO, V11, P315
  • [2] Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation
    Abe, A
    Gregory, S
    Lee, L
    Killen, PD
    Brady, RO
    Kulkarni, A
    Shayman, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) : 1563 - 1571
  • [3] Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO
  • [4] 2-C
  • [5] Acampora D, 1999, DEVELOPMENT, V126, P3795
  • [6] ALDRED MJ, 1992, HUM GENET, V90, P413
  • [7] [Anonymous], 1993, Society and animals, DOI [DOI 10.1163/156853093X00172, 10.1163/156853093X00172]
  • [8] Perlecan is essential for cartilage and cephalic development
    Arikawa-Hirasawa, E
    Watanabe, H
    Takami, H
    Hassell, JR
    Yamada, Y
    [J]. NATURE GENETICS, 1999, 23 (03) : 354 - 358
  • [9] Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene
    Arikawa-Hirasawa, E
    Wilcox, WR
    Le, AH
    Silverman, N
    Govindraj, P
    Hassell, JR
    Yamada, Y
    [J]. NATURE GENETICS, 2001, 27 (04) : 431 - 434
  • [10] MOUSE AND HAMSTER MUTANTS AS MODELS FOR WAARDENBURG SYNDROMES IN HUMANS
    ASHER, JH
    FRIEDMAN, TB
    [J]. JOURNAL OF MEDICAL GENETICS, 1990, 27 (10) : 618 - 626